[Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report]

Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Aug 18;55(4):748-754. doi: 10.19723/j.issn.1671-167X.2023.04.029.
[Article in Chinese]

Abstract

Peritoneal dialysis (PD) catheter-related infection (i.e. exit-site infection and tunnel infection) is one of the main causes of PD-related peritonitis. If it cannot be controlled effectively, it could lead to PD technique failure. Therefore, timely and effective diagnosis and treatment and active prevention so as to reduce PD catheter-related infection is an important treatment goal in PD patients. PD catheter exit-site infection (ESI) and tunnel infection can be caused by a variety of microorganisms, mainly bacteria, while fungi are very rare. Few public data can be used to guide treatment of PD catheter-related fungal infection, and there is no related report in China till now. Once fungal peritonitis occurred, the patient can only withdraw from PD treatment. Here, we report a case of fungal PD catheter ESI combined with tunnel infection which was successfully diagnosed and treated in our PD center. A 71-year-old woman came to clinic because of "PD for 5 years, secretions from exit site for 8 days and aggravation for 1 day". The patient suffered from peritonitis, ESI and tunnel infection for many times in the past 5 years, involving a variety of pathogens. Eight days before, she found white viscous discharge from exit site. The subcutaneous cuff completely came out of it and rubbed its skin. The Schaefer exit-site score was 3 points. Due to the suspected ESI 2 months before, the discharge swab for bacterial culture was positive for Pseudomonas aeruginosa, so the exit site swab for bacterial culture was done again, and gentamicin injection was applied topically once a day for empirical treatment. The exit site was evaluated one day before: The subcutaneous tunnel was significantly swollen and slightly tender at 2.5 cm away from the exit site, and with white medium amount of viscous secretions. The exit-site score increased to 4 points. Routine test of dialysis effluent was (-). The bacterial culture of the exit-site discharge was rechecked twice, and Candida parapsilosis was positive for two times, so the diagnosis of fungal PD catheter ESI combined with tunnel infection was clear. Immediately we searched for the causes of ESI and tunnel infection. We found that the patient had a suspicious history of gray toenail on the foot. The toenail smear was positive for fungi and visible hyphae. She washed feet with hands every day, and washed clothes on a low bench every day, which made the exit-site and tunnel squeezed for a long time. Based on the above causes, we gave her comprehensive treatment as follows: For ESI and tunnel fungal infections, fluco-nazole was used systemically according to the drug sensitivity results, and miconazole cream was applied to the exit-site locally. For the subcutaneous cuff that came out completely, daily iodophor disinfection was given locally. At the same time, local antifungal treatment was given to the foot. We followed up closely during treatment, evaluated the exit-site every 2-3 days, and took photos of the exit-site to dynamically observe the effect. After 14 days of treatment, the exit-site score continued to be 0-1, the bacterial culture of the exit-site was negative, the cuff culture was negative, and the tunnel B-ultrasound was normal. The patient had been followed up regularly once a month for 60 months, no ESI and tunnel infection occurred. Fungal PD catheter ESI and tunnel infection are rare complications of PD. When the standard anti-infection treatment is ineffective, the possibility of fungal infection should be considered, so as to avoid prolonged use of antibiotics, aggravating fungal infection, and even progressing to fungal peritonitis, leading to withdrawal from PD. Accurate exit-site evaluation is helpful for timely diagnosis and early treatment of ESI and tunnel infection. The exit-site discharge culture and drug sensitivity test before treatment are helpful to identify the pathogen and adjust subsequent treatment. At the same time, repeated discharge culture is required in order to exclude positive fungal culture results caused by contamination. Once fungal catheter-related infection is diagnosed, we should search for possible causes actively, subsequent targeted and comprehensive treatment plays a decisive role for the prognosis of patients.

腹膜透析(peritoneal dialysis, PD)导管相关感染(即出口感染和隧道感染)是PD相关腹膜炎的主要诱因之一,如不能有效控制,严重者可导致腹膜透析导管拔除、腹膜透析技术失败,因此积极预防和及时有效的诊治以减少导管相关感染是PD患者日常管理的重要目标。腹膜透析导管出口感染和隧道感染可由多种微生物引起,以细菌为主,真菌极为罕见,目前可用来指导治疗的公开数据很少,且国内尚未见报道。一旦继发真菌性腹膜炎,患者只能退出腹膜透析治疗。现将北京大学人民医院肾内科成功诊治的1例真菌性腹膜透析导管出口感染合并隧道感染的病例分享如下, 患者女性,71岁,因“腹膜透析5年,出口处分泌物8天,加重1天”就诊。患者5年间多次患腹膜炎、PD导管出口感染及隧道感染,涉及多种病原体。8 d前评估患者出口见白色黏稠分泌物,距出口1 cm处皮肤暗红、发硬,浅层涤纶套完全脱出、摩擦出口边缘,Schaefer出口评分3分。因2个月前可疑出口感染,分泌物培养铜绿假单胞菌阳性,故再次留取分泌物细菌培养后,每日1次局部使用庆大霉素注射液外敷经验性治疗。1 d前评估出口发现皮下隧道段距出口2.5 cm处明显肿胀、轻压痛,可见白色中量黏稠分泌物,出口评分4分。化验腹膜透析流出液常规(-);先后两次复查出口分泌物细菌培养,近平滑念珠菌均阳性,故真菌性PD导管出口感染合并隧道感染诊断明确。立即寻找出口、隧道感染的原因及诱因,发现患者足部可疑灰趾甲病史,此次趾甲涂片真菌阳性、可见菌丝;并每日用手洗脚,同时每天坐矮板凳洗衣服,使出口及隧道长期受到挤压。基于上述诱因,给予综合性治疗:针对出口、隧道真菌感染,根据药敏结果给予氟康唑全身用药、辅以出口局部碘伏消毒后硝酸咪康唑乳膏外用;针对脱出的浅层涤纶套, 局部予每日碘伏消毒;同时予足部局部抗真菌治疗。治疗期间密切随访,每2~3天评估出口,并留存出口照片以动态观察疗效。总疗程14 d后,出口评分持续0~1分,复查出口处细菌培养阴性,涤纶套培养阴性,隧道B超正常,故更改为常规出口护理。每月规律随访,60个月未再发生出口及隧道感染。真菌性PD导管出口感染、隧道感染是腹膜透析的少见并发症,当进行规范的抗感染治疗无效时, 要考虑到真菌感染的可能,从而避免因为按细菌感染治疗,延长抗生素的应用时间,加重真菌感染,甚至进展至真菌性腹膜炎,退出腹膜透析。准确的出口评估有助于出口、隧道感染的及时诊断、尽早治疗。在治疗前行出口分泌物细菌培养及药敏试验有助于确定病原体、调整后续治疗;同时,为排除污染所致的真菌培养阳性,需要重复细菌培养。一旦确诊为真菌性导管相关感染,应积极寻找可能诱因,针对性且全面的治疗对患者的预后有决定作用。

Keywords: Exit-site infection; Fungus; Peritoneal dialysis; Tunnel infection.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Catheter-Related Infections* / drug therapy
  • Catheter-Related Infections* / etiology
  • Catheter-Related Infections* / prevention & control
  • Catheters, Indwelling / adverse effects
  • Female
  • Humans
  • Mycoses* / complications
  • Mycoses* / etiology
  • Peritoneal Dialysis* / adverse effects
  • Peritonitis* / drug therapy
  • Peritonitis* / etiology

Grants and funding

北京大学人民医院研究与发展基金(RDN 2013-02)